159 related articles for article (PubMed ID: 15072840)
1. Synthesis and serotonergic activity of variously substituted (3-amido)phenylpiperazine derivatives and benzothiophene-4-piperazine derivatives: novel antagonists for the vascular 5-HT1B receptor.
Moloney GP; Garavelas A; Martin GR; Maxwell M; Glen RC
Eur J Med Chem; 2004 Apr; 39(4):305-21. PubMed ID: 15072840
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and serotonergic activity of substituted 2, N-benzylcarboxamido-5-(2-ethyl-1-dioxoimidazolidinyl)-N, N-dimethyltryptamine derivatives: novel antagonists for the vascular 5-HT(1B)-like receptor.
Moloney GP; Martin GR; Mathews N; Milne A; Hobbs H; Dodsworth S; Sang PY; Knight C; Williams M; Maxwell M; Glen RC
J Med Chem; 1999 Jul; 42(14):2504-26. PubMed ID: 10411472
[TBL] [Abstract][Full Text] [Related]
3. [N-methyl-3H3]AZ10419369 binding to the 5-HT1B receptor: in vitro characterization and in vivo receptor occupancy.
Maier DL; Sobotka-Briner C; Ding M; Powell ME; Jiang Q; Hill G; Heys JR; Elmore CS; Pierson ME; Mrzljak L
J Pharmacol Exp Ther; 2009 Jul; 330(1):342-51. PubMed ID: 19401496
[TBL] [Abstract][Full Text] [Related]
4. 5-Hydroxytryptamine1B receptor-mediated contraction of rabbit saphenous vein and basilar artery: role of vascular endothelium.
Bhattacharya A; Schenck KW; Xu YC; Nisenbaum L; Galbreath E; Cohen ML
J Pharmacol Exp Ther; 2004 May; 309(2):825-32. PubMed ID: 14724223
[TBL] [Abstract][Full Text] [Related]
5. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.
Leopoldo M; Berardi F; Colabufo NA; Contino M; Lacivita E; Niso M; Perrone R; Tortorella V
J Med Chem; 2004 Dec; 47(26):6616-24. PubMed ID: 15588097
[TBL] [Abstract][Full Text] [Related]
6. SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'methyl-4'-(5-methyl-1,2,3-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): a novel, potent and selective 5-HT1B receptor antagonist.
Scott C; Langmead CJ; Clarke KL; Wyman P; Smith PW; Starr KR; Dawson LA; Price GW; Hagan JJ; Watson J
Neuropharmacology; 2006 Jun; 50(8):984-90. PubMed ID: 16546225
[TBL] [Abstract][Full Text] [Related]
7. WAY 405, a new silent 5-HT (1A) receptor antagonist with low affinity for vascular alpha (1)-adrenoceptors.
Villalobos-Molina R; Orozco-Méndez M; López-Guerrero JJ; Gallardo-Ortíz IA
Auton Autacoid Pharmacol; 2005 Oct; 25(4):185-9. PubMed ID: 16176451
[TBL] [Abstract][Full Text] [Related]
8. In vitro characterization of AR-A000002, a novel 5-hydroxytryptamine(1B) autoreceptor antagonist.
Ahlgren C; Eriksson A; Tellefors P; Ross SB; Stenfors C; Malmberg A
Eur J Pharmacol; 2004 Sep; 499(1-2):67-75. PubMed ID: 15363952
[TBL] [Abstract][Full Text] [Related]
9. Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats.
Jeong CY; Choi JI; Yoon MH
Eur J Pharmacol; 2004 Oct; 502(3):205-11. PubMed ID: 15476746
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and SAR of highly potent dual 5-HT1A and 5-HT1B antagonists as potential antidepressant drugs.
Kling A; Lange UE; Mack H; Bakker MH; Drescher KU; Hornberger W; Hutchins CW; Möller A; Müller R; Schmidt M; Unger L; Wicke K; Schellhaas K; Steiner G
Bioorg Med Chem Lett; 2005 Dec; 15(24):5567-73. PubMed ID: 16219465
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of 5-HT2C receptor ligands on place conditioning and locomotor activity in rats.
Mosher T; Hayes D; Greenshaw A
Eur J Pharmacol; 2005 May; 515(1-3):107-16. PubMed ID: 15896731
[TBL] [Abstract][Full Text] [Related]
12. Structure-intrinsic activity relationship studies in the group of 1-imido/amido substituted 4-(4-arylpiperazin-1-yl)cyclohexane derivatives; new, potent 5-HT1A receptor agents with anxiolytic- like activity.
Bojarski AJ; Paluchowska MH; Duszyńska B; Bugno R; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
Bioorg Med Chem; 2006 Mar; 14(5):1391-402. PubMed ID: 16266808
[TBL] [Abstract][Full Text] [Related]
13. Roles of 5-hydroxytryptamine (5-HT) receptor subtypes in the inhibitory effects of 5-HT on C-fiber responses of spinal wide dynamic range neurons in rats.
Liu FY; Xing GG; Qu XX; Xu IS; Han JS; Wan Y
J Pharmacol Exp Ther; 2007 Jun; 321(3):1046-53. PubMed ID: 17329553
[TBL] [Abstract][Full Text] [Related]
14. Effects of SL 65.0472, a novel 5-HT receptor antagonist, on 5-HT receptor mediated vascular contraction.
Galzin AM; Delahaye M; Hoornaert C; McCort G; O'Connor SE
Eur J Pharmacol; 2000 Sep; 404(3):361-8. PubMed ID: 10996601
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and SAR of 3- and 4-substituted quinolin-2-ones: discovery of mixed 5-HT(1B)/5-HT(2A) receptor antagonists.
McCort G; Hoornaert C; Aletru M; Denys C; Duclos O; Cadilhac C; Guilpain E; Dellac G; Janiak P; Galzin AM; Delahaye M; Guilbert F; O'Connor S
Bioorg Med Chem; 2001 Aug; 9(8):2129-37. PubMed ID: 11504649
[TBL] [Abstract][Full Text] [Related]
16. Preparation of piperazine derivatives as 5-HT7 receptor antagonists.
Yoon J; Yoo EA; Kim JY; Pae AN; Rhim H; Park WK; Kong JY; Park Choo HY
Bioorg Med Chem; 2008 May; 16(10):5405-12. PubMed ID: 18456500
[TBL] [Abstract][Full Text] [Related]
17. APD791, 3-methoxy-n-(3-(1-methyl-1h-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide, a novel 5-hydroxytryptamine 2A receptor antagonist: pharmacological profile, pharmacokinetics, platelet activity and vascular biology.
Adams JW; Ramirez J; Shi Y; Thomsen W; Frazer J; Morgan M; Edwards JE; Chen W; Teegarden BR; Xiong Y; Al-Shamma H; Behan DP; Connolly DT
J Pharmacol Exp Ther; 2009 Oct; 331(1):96-103. PubMed ID: 19628629
[TBL] [Abstract][Full Text] [Related]
18. Modification of the structure of 4, 6-disubstituted 2-(4-alkyl-1-piperazinyl)pyridines: synthesis and their 5-HT2A receptor activity.
Paluchowska MH; Bojarski AJ; Bugno R; Charakchieva-Minol S; Wesołowska A
Arch Pharm (Weinheim); 2003 Apr; 336(2):104-10. PubMed ID: 12761763
[TBL] [Abstract][Full Text] [Related]
19. Antiarrhythmic, serotonin antagonist and antianxiety activities of novel substituted thiophene derivatives synthesized from 2-amino-4,5,6,7-tetrahydro-N-phenylbenzo[b]thiophene-3-carboxamide.
Amr Ael-G; Sherif MH; Assy MG; Al-Omar MA; Ragab I
Eur J Med Chem; 2010 Dec; 45(12):5935-42. PubMed ID: 20950897
[TBL] [Abstract][Full Text] [Related]
20. The anxiolytic-like effect of 5-HT1B receptor ligands in rats: a possible mechanism of action.
Chojnacka-Wójcik E; Kłodzińska A; Tatarczyńska E
J Pharm Pharmacol; 2005 Feb; 57(2):253-7. PubMed ID: 15720791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]